Patent ID: 11913039
Assignee: ALEXION PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 13:
14. The method of claim 1, wherein the recombinant alkaline phosphatase comprises the structure of W-sALP-X-Fc-Y-Dn-Z, wherein
W is absent or is an amino acid sequence of at least one amino acid;
X is absent or is an amino acid sequence of at least one amino acid;
Y is absent or is an amino acid sequence of at least one amino acid;
Z is absent or is an amino acid sequence of at least one amino acid;
F c is a fragment crystallizable region;
Dn is a poly-aspartate, poly-glutamate, or combination thereof, wherein n=10 or 16; and
sALP is a soluble alkaline phosphatase.